Edulan, Gerley T.

HRN: 09-57-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2025
CEFUROXIME 500MG (TAB)
08/12/2025
08/18/2025
ORAL
500mg
Q12
S/P NSVD
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines